We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!

WBCPI 100.32 0.0% BHP 45.37 0.688% CBA 134.61 0.313% RIO 126.04 0.0635% CSL 288.61 0.554% NAB 37.0 0.0541% WBC 30.71 -1.2858% ANZ 30.08 -0.0996% NEM 78.24 0.0384% MQG 226.55 0.1724% WES 69.03 0.0725% GMG 37.8 1.5583% FMG 19.98 -0.7944% SQ2 94.0 -1.3848% RMD 34.76 -0.4582% WDS 26.06 0.5789% WTC 134.6 -0.3553% TLS 3.88 -0.5128% TCL 13.19 0.7639% WOW 33.01 0.1213%

Mar 26, 2024

OPRA
Investment Type
Small-Cap
Risk Level
Action
Rec. Price ()

Section 1: Company Overview and Fundamentals

1.1 Company Overview:

Opera Ltd (NASDAQ: OPRA) is a Norway-based technology company that is engaged in the web browser development. The Company operates as a provider of browser and integrated artificial intelligence (AI)-driven digital content discovery and recommendation platforms. The Company’s operations are comprised of search, advertising, technology licensing and other.

Kalkine’s American Tech Report covers the Company Overview, Key positives & negatives, Investment summary, Key investment metrics, Top 10 shareholding, Business updates and insights into company recent financial results, Key Risks & Outlook, Price performance and technical summary, Target Price, and Recommendation on the stock.

  Stock Performance:

  • OPRA has given returns of 21.60% in the past three months, while with a 16.36% return in the past six months.
  • The stock is leaning towards its lower band of its 52-week range of USD 28.58 and 52-week low price of USD 9.15. Post the announcement of FY23 results the stock has given a return of around 30.78%, with currently price is currently near an important support zone of USD 12.00-USD 14.00.
  • The price is currently trading above its long-term (200-day) SMA and its short-term (50-day) SMA, with the current RSI of around 64.41.

1.2 The Key Positives, Negatives, and Investment summary

1.3 Key Metrics:

Opera Limited has shown consistent growth in revenue from 2019 to 2023, with figures rising from USD 177.1 million to USD 397.5 million. The gross profit also witnessed a steady increase over the same period, progressing from USD 174.5 million to USD 304.2 million. In terms of net margin, Opera Ltd has exhibited resilience in net margins, outperforming the industry median of -7.1% to a robust 42.6% in 2023. This positive trend underscores Opera's financial strength and efficiency, positioning the company favorably within its industry.

1.4 Top 10 shareholders:

The top 10 shareholders together form ~7.95% of the total shareholding, signifying diverse shareholding. Marshall Wace LLP and Beijing Kunlun Tech Co Ltd are the biggest shareholders, holding the maximum stake in the company at ~1.40% and ~1.34%, respectively.

Section 2: Business Updates and Corporate Business Highlights

2.1 Recent Updates:

The below picture gives an overview of the recent updates:

 2.2 Insights of FY23:

Section 3: Key Risks and Outlook

Section 4: Stock Recommendation Summary:

4.1 Price Performance and Technical Summary:

  Stock Performance:

  • OPRA has given returns of 21.60% in the past three months, while with a 16.36% return in the past six months.
  • The stock is leaning towards its lower band of its 52-week range of USD 28.58 and 52-week low price of USD 9.15. Post the announcement of FY23 results the stock has given a return of around 30.78%, with currently price is currently near an important support zone of USD 12.00-USD 14.00.
  • The price is currently trading above its long-term (200-day) SMA and its short-term (50-day) SMA, with the current RSI of around 64.41.

 

4.2 Fundamental Valuation

Valuation Methodology: Price/Earnings per share Multiple Based Relative Valuation

Markets are trading in a highly volatile zone currently due to certain macroeconomic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is March 25, 2024. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: The report publishing date is as per the Pacific Time Zone.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

 Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

 Stop-loss: It is a level to protect against further losses in case of unfavorable movement in the stock prices.


Disclaimer

Kalkine New Zealand Limited is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity financial products. The recommendations and opinions [on this website] / [in this report] do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine).  Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website.  Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.